Fluidx Medical’s Embolic Demonstrates Novel Visibility Advantage
- Wednesday, February 2, 2022, 7:18
- Business
- Add a comment
SALT LAKE CITY, Feb. 2, 2022 /PRNewswire/ — Fluidx Medical Technology announces results of its GPX-Clear Embolic Device in-vivo research which uses the base GPX technology and incorporates an intermediate term radiopacity agent. “Our initial in-vivo work with GPX-Clear looks very…
About the Author
adminasapcorp has written 39773 stories on this site.